Judith A. Smith

3.9k total citations
121 papers, 3.1k citations indexed

About

Judith A. Smith is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Judith A. Smith has authored 121 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 27 papers in Surgery and 20 papers in Oncology. Recurrent topics in Judith A. Smith's work include Ovarian cancer diagnosis and treatment (13 papers), Metabolism, Diabetes, and Cancer (9 papers) and Cancer therapeutics and mechanisms (8 papers). Judith A. Smith is often cited by papers focused on Ovarian cancer diagnosis and treatment (13 papers), Metabolism, Diabetes, and Cancer (9 papers) and Cancer therapeutics and mechanisms (8 papers). Judith A. Smith collaborates with scholars based in United States, United Kingdom and Australia. Judith A. Smith's co-authors include Leonard Jarett, Andrew J. Goudie, Jeffrey A. Bluestone, Judith K. Wolf, Fred H. Katz, Diane C. Bodurka, J. Yun Tso, Shuko Harada, Michael S. Cole and Marcus R. Clark and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Judith A. Smith

120 papers receiving 3.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Judith A. Smith 847 565 467 466 309 121 3.1k
Fuu‐Jen Tsai 1.6k 1.9× 450 0.8× 334 0.7× 343 0.7× 375 1.2× 275 4.2k
Robin Bliss 775 0.9× 587 1.0× 493 1.1× 442 0.9× 178 0.6× 72 3.4k
Adel Abuzenadah 1.2k 1.5× 332 0.6× 240 0.5× 230 0.5× 276 0.9× 178 3.7k
Hong‐Chiang Chang 1.4k 1.7× 387 0.7× 385 0.8× 324 0.7× 502 1.6× 144 3.2k
Masato Maekawa 1.6k 1.9× 604 1.1× 486 1.0× 392 0.8× 316 1.0× 222 3.9k
Εkaterini Chatzaki 891 1.1× 326 0.6× 168 0.4× 258 0.6× 190 0.6× 116 2.8k
Vladisav Stefanović 756 0.9× 607 1.1× 386 0.8× 198 0.4× 118 0.4× 153 2.9k
Tomoko Nakamura 1.5k 1.7× 456 0.8× 371 0.8× 432 0.9× 283 0.9× 187 4.3k
Nicholas P. Illsley 1.0k 1.2× 230 0.4× 312 0.7× 398 0.9× 324 1.0× 95 4.1k
Emma D. Deeks 1.4k 1.6× 1.1k 1.9× 386 0.8× 528 1.1× 161 0.5× 156 5.0k

Countries citing papers authored by Judith A. Smith

Since Specialization
Citations

This map shows the geographic impact of Judith A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith A. Smith more than expected).

Fields of papers citing papers by Judith A. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith A. Smith. The network helps show where Judith A. Smith may publish in the future.

Co-authorship network of co-authors of Judith A. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Judith A. Smith. A scholar is included among the top collaborators of Judith A. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith A. Smith. Judith A. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Judith A., et al.. (2025). A review of mirvetuximab soravtansine-gynx in folate receptor alpha–expressing platinum-resistant ovarian cancer. American Journal of Health-System Pharmacy. 82(10). 522–536. 3 indexed citations
2.
Smith, Judith A., et al.. (2024). IdentiFLY: The Development and Validation of a 15-Plex SNP Assay for Forensic Identification of UK Blowfly Species (Calliphoridae). SHILAP Revista de lepidopterología. 4(4). 680–695. 1 indexed citations
3.
Smith, Judith A., et al.. (2018). Identifying the need to refine the potential patient risk factors for niraparib-induced thrombocytopenia. Gynecologic Oncology. 152(2). 265–269. 3 indexed citations
4.
Smith, Judith A., et al.. (2015). Evaluating the potential effect on fetal tissue after exposure to granisetron during pregnancy. Reproductive Toxicology. 53. 92–98. 5 indexed citations
5.
Smith, Harry, et al.. (2013). Virus-associated apoptosis of blood neutrophils as a risk factor for invasive meningococcal disease. Journal of Clinical Pathology. 66(11). 976–981. 1 indexed citations
6.
Smith, Judith A., et al.. (2013). Utilization of an ex vivo human placental perfusion model to predict potential fetal exposure to carboplatin during pregnancy. American Journal of Obstetrics and Gynecology. 210(3). 275.e1–275.e9. 22 indexed citations
7.
Hunter, Rodney J., et al.. (2012). Granisetron Transdermal Patch for Treatment of Nausea in Patients Undergoing Cisplatin Based Chemotherapy for Cervical Cancer. Journal of Cancer Therapy. 3(6). 1159–1163. 1 indexed citations
8.
Lowry, Ashley M., Russell E. Lewis, Richard D. Lozano, et al.. (2011). Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinoma. Journal of Antimicrobial Chemotherapy. 67(2). 422–429. 5 indexed citations
9.
10.
Ramírez, Pedro T., Kathleen M. Schmeler, Michael R. Milam, et al.. (2008). Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum. Gynecologic Oncology. 110(1). 56–59. 55 indexed citations
11.
Smith, Judith A., et al.. (2007). In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines. Cancer Chemotherapy and Pharmacology. 62(3). 483–489. 31 indexed citations
12.
Smith, Judith A., et al.. (2006). Determination of the mechanism of gemcitabine modulation of cisplatin drug resistance in panel of human endometrial cancer cell lines. Gynecologic Oncology. 103(2). 518–522. 17 indexed citations
13.
Smith, Judith A., et al.. (2005). An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines. Gynecologic Oncology. 98(1). 141–145. 64 indexed citations
14.
15.
Solow, Barbara T., et al.. (1999). Angiotensin II Inhibits Insulin-Induced egr-1 Expression in Mesangial Cells. Archives of Biochemistry and Biophysics. 370(2). 308–313. 5 indexed citations
16.
Smith, Judith A., et al.. (1999). Does MK-801 Discrimination Constitute an Animal Model of Schizophrenia Useful for Detecting Atypical Antipsychotics?. Pharmacology Biochemistry and Behavior. 64(2). 429–433. 7 indexed citations
17.
Smith, Judith A., J. Yun Tso, Marcus R. Clark, Michael S. Cole, & Jeffrey A. Bluestone. (1997). Nonmitogenic Anti-CD3 Monoclonal Antibodies Deliver a Partial T Cell Receptor Signal and Induce Clonal Anergy. The Journal of Experimental Medicine. 185(8). 1413–1422. 167 indexed citations
18.
Smith, Judith A. & J A Bluestone. (1997). T cell inactivation and cytokine deviation promoted by anti-CD3 mAbs. Current Opinion in Immunology. 9(5). 648–654. 54 indexed citations
19.
Harada, Shuko, Robert M. Smith, Judith A. Smith, et al.. (1995). Insulin-induced egr-1 Expression in Chinese Hamster Ovary Cells Is Insulin Receptor and Insulin Receptor Substrate-1 Phosphorylation-independent. Journal of Biological Chemistry. 270(44). 26632–26638. 12 indexed citations
20.
Burton, Robert C., et al.. (1978). Effects of placental tissue on immunological responses.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 34(3). 441–8. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fuu‐Jen Tsai Breakdown of academic impact, for papers by Robin Bliss Breakdown of academic impact, for papers by Adel Abuzenadah Breakdown of academic impact, for papers by Hong‐Chiang Chang Breakdown of academic impact, for papers by Masato Maekawa Breakdown of academic impact, for papers by Εkaterini Chatzaki Breakdown of academic impact, for papers by Vladisav Stefanović Breakdown of academic impact, for papers by Tomoko Nakamura Breakdown of academic impact, for papers by Nicholas P. Illsley Breakdown of academic impact, for papers by Emma D. Deeks
Rankless by CCL
2026